RecruitingNCT06765226
Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps
Abiomed Impella Pump Return Registry - Observational Study
Sponsor
Abiomed Inc.
Enrollment
200 participants
Start Date
Sep 21, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Analysis of cell and protein deposits on the Impella Heart Pump.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients with Impella 5.5 therapy and duration of support for ≥ 25 days OR Patients with Impella CP therapy and duration of support for \> 4 days
Exclusion Criteria1
- Age \< 18 years
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06765226
Related Trials
Mind Your Heart-II
NCT054311921 location
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations